Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2026-01-02 @ 5:55 AM
Study NCT ID:
NCT03991403
Status:
UNKNOWN
Last Update Posted:
2023-04-03
First Post:
2019-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC
Sponsor:
Samsung Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-27
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-11
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-05
First Submit QC Date:
None
Study First Post Date:
2019-06-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-29
Last Update Post Date:
2023-04-03
Last Update Post Date Type:
ACTUAL